(Q30405818)

21 June 2017

title

Serious adverse events following receipt of trivalent inactivated influenza vaccine in Korea, 2003-2010. (English)

1 reference

21 June 2017

1 reference

Young June Choe

1

1 reference

21 June 2017

Heeyeon Cho

2

1 reference

21 June 2017

Sung Nam Kim

3

1 reference

21 June 2017

Geun-Ryang Bae

4

1 reference

21 June 2017

Jong-Koo Lee

5

1 reference

21 June 2017

language of work or name

English

0 references

publication date

7 August 2011

1 reference

21 June 2017

1 reference

21 June 2017

volume

29

1 reference

21 June 2017

issue

44

1 reference

21 June 2017

page(s)

7727-7732

1 reference

Values for preventing influenza-related morbidity and vaccine adverse events in children

21 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.129

Adverse reactions to influenza vaccine in elderly people: randomised double blind placebo controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.129

Comparative trial of influenza vaccines. II. Adverse reactions in children and adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.129

Safety of trivalent inactivated influenza vaccine in children 6 to 23 months old.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.129

Serious adverse events rarely reported after trivalent inactivated influenza vaccine (TIV) in children 6-23 months of age.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.129

Safety of trivalent inactivated influenza vaccines in adults: background for pandemic influenza vaccine safety monitoring.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.129

Guillain-Barre syndrome following vaccination in the National Influenza Immunization Program, United States, 1976--1977

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.129

Guillain–Barré syndrome and Fisher syndrome: Case definitions and guidelines for collection, analysis, and presentation of immunization safety data

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.129

Anaphylaxis: case definition and guidelines for data collection, analysis, and presentation of immunization safety data

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.129

Cellulitis at injection site: case definition and guidelines for collection, analysis, and presentation of immunization safety data

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.129

Vaccines and Guillain-Barré syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.129

Safety of influenza A (H1N1) vaccine in postmarketing surveillance in China

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.129

Guillain-Barré syndrome following influenza vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.129

Evaluation of Guillain-Barré Syndrome Among Recipients of Influenza Vaccine in 2000 and 2001

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.129

7 January 2021

Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.129

Monitoring the safety of annual and pandemic influenza vaccines: lessons from the US experience.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.129

Prevalence of stroke and transient ischemic attack in Korean elders: findings from the Korean Longitudinal Study on Health and Aging (KLoSHA).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.129

Influenza vaccination and reduction in hospitalizations for cardiac disease and stroke among the elderly

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.129

Post-vaccination encephalomyelitis: literature review and illustrative case

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.129

Anaphylaxis from the influenza virus vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.129

Verdachtsf�lle von Impfkomplikationen nach dem Infektionsschutzgesetz und Verdachtsf�lle von Nebenwirkungen nach dem Arzneimittelgesetz vom 1.1.2001 bis zum 31.12.2003

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.129

Descriptive epidemiology of adverse events after immunization: reports to the Vaccine Adverse Event Reporting System (VAERS), 1991-1994.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.129

10.1016/J.VACCINE.2011.07.129

7 January 2021

Identifiers

DOI

1 reference

release_6bv2hkkdd5ggnhetb4m2orxl64

21 June 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/6bv2hkkdd5ggnhetb4m2orxl64

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference